GTC presented abstracts at ASH 2024
GTC’s posters from 2024 Convention of American Society of Hematology are now available to be downloaded. Please reach out with any questions.
Establishing a Distinct Cytokine Signature for Multiple Myeloma
Using Bone Marrow RNA and Peripheral Blood Cell-Free RNA (cfRNA)
Establishing Distinct Cytokine Signatures Differentiating between Acute Myeloid Leukemia, Myelodysplastic Syndrome, and Chip Using Bone Marrow RNA or Cell-Free RNA (cfRNA)
Establishing Lymphoma Type-Specific Cytokine Signatures
Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA)
Clonotype- naive Detection Of Clonality in Patients Suspected of Having Multiple Myeloma or Monoclonal Gammopathy Using Peripheral Blood Cell-Free RNA (cfRNA)
Read more Articles and News from GTC
ASH 67th Annual Meeting & Exposition
The largest gathering in hematology, combining scientific sessions, poster presentations, and exhibits with abstracts submission available until August 5, 2025
SNO (Society for Neuro‑Oncology) Annual Meeting
The premier neuro-oncology conference featuring the World Federation of Neuro-Oncology and Society for Neuro-Oncology quadrennial meeting, highlighting advances in brain tumor research and clinical practice.
AMP (Association for Molecular Pathology) Annual Meeting & Expo
The flagship event of the Association for Molecular Pathology, uniting molecular diagnostics professionals for workshops, poster sessions, scientific presentations, and an extensive expo.
2025 Park City Myeloma & Lymphoma Summit
This summit is a CME/ACPE‑accredited event that unites leading experts in hematologic malignancies to deliver updates on emerging strategies and advances in the treatment of
Binaytara Hematology (5th Precision Oncology Summit)
A CME-accredited, two-day national summit showcasing molecular-targeted cancer therapies, featuring expert-led sessions on precision medicine approaches.
SOHO (Society of Hematologic Oncology)
The 13th Annual Society of Hematologic Oncology meeting covers cutting-edge advances in blood cancer treatment, with a special theme on AI-driven diagnostics and therapeutic strategies.